Objectives. The impact of pharmaceutical sales representatives (PSRs) and the health professional curriculum on the cost of pharmacotherapy during the early stage of professional training was investigated. Methods. We used a cross-sectional survey design to assess the cost of pharmacotherapy choices and interaction with PSRs among senior medical, PharmD, and nurse practitioner students. Three clinical scenarios offered 4 options for medications that were equally efficacious but had widely varying costs; a relative value index was used to calculate pharmacotherapy costs. Results. Fifty-nine medical, 53 PharmD, and 17 nurse practitioner students volunteered to participate. Medical and nurse practitioner students reported more interaction with PSRs (P = 0.002). There were significant differences among groups for the total composite cost of drugs prescribed (P < 0.001) and for all 3 scenarios (tendinitis P < 0.001; hypertension P < 0.001; UTI P = 0.029). Conclusions. For all scenarios, pharmacy students chose less expensive agents than the other groups. Whether differences in pharmacotherapy costs were due to curriculum content to which each group of students was exposed or to their interactions with PSRs have yet to be determined.
INTRODUCTION
Prescription drug costs are increasing at a higher rate than other health care expenditures. During the 1990s prescription drug costs rose by 141%, physician costs by 71%, and hospital costs by 54%. 1 Drug costs affect employer-based health insurance premiums. 2 Up to one third of recent increases in health insurance premiums are attributed to increases in prescription drug expenses.
Prescribing costs can impact prescription drug expenditures. What factors influence prescribing expenses during the early stages of professional training? Wanaza recently examined the pharmaceutical industry's influence on physician knowledge, attitudes, and behavior. 3 Data from 29 studies showed that physicians began interacting with pharmaceutical sales representatives (PSRs) while in medical school at a rate of approximately 4 times per month. Also, medical residents and physicians believed that the PSRs provided accurate drug information. Finally, attending sponsored educational symposia resulted in an increased rate of prescriptions for the sponsor's medications. We hypothesized that at least 2 factors may affect prescribing practices early in a health professional's education: interaction with PSRs and the curriculum.
METHODS

Study Design
Senior-level medical students, PharmD students, and nurse practitioner students were surveyed to assess their pharmacotherapy costs and their interactions with and attitudes toward PSRs. A cross-sectional survey design was used to assess 3 groups of health professional students, regarding cost-conscious pharmacotherapeutic decision-making and interactions with PSRs. All stu- 
Survey Instrument
The survey instrument was developed specifically for this study. A table of specifications was used to define the domain of interest and the respective item sampling. The items were developed through a review of the medical literature and consultation with senior clinicians in the departments of internal medicine and pharmacy practice. Surveys were adapted to the particular professional student. For example, items relating to prescribing were worded so that pharmacy students were asked to make a therapeutic recommendation on the most appropriate agent versus the agent actually prescribed. The items were field tested through a focus group consisting of senior internal medicine residents and faculty from the schools of pharmacy and nursing. This review consisted of having the participants complete the survey and provide feedback regarding its accuracy and clarity. For example, the determination of equivalency of agents used in the survey was addressed by asking the respondents "Do you consider the agents used in the vignettes equivalent." Subsequent item review and refinement enhanced content validity. 4, 5 Three clinical scenarios (see Table 3 ) representing common ambulatory problems (supraspinatus tendinitis, mild hypertension, and acute cystitis) were used to assess the costs of pharmacotherapy decisions (prescribing for medical and nurse practitioner students or therapeutic recommendations for pharmacy students). Each scenario offered 4 medication choices of equal efficacy but widely varying costs. Students were asked to rate the likelihood of recommending/prescribing each of the drugs for each scenario. Due to the great variation in costs of available medications to treat common ambulatory problems, comparing the relative costs among drug choices may vary tremendously among the least to most expensive. For this reason we developed a relative value index to compare the cost of pharmacotherapy for each student. Each drug choice in each scenario was assigned a ranked score relative to the other choices based on the average wholesale price for a 30-day supply. 6 The most expensive choice received a score of 3, the intermediate, a score of 2, and the least expensive, a score of 1. For example, in the first scenario, the cost of a 30-day for arthritis treatment was $85 to $172 (100 to 200 mg twice daily of celecoxib), $83 (50/200 or 75/200 daily for diclofenac/misoprostol), $3 to $7 (400 or 800 mg three to four times daily for ibuprofen), and $69 (500 mg twice daily for nabumetone). The relative ranked values assigned were 3, 3, 1, 2, respectively. The relative value index was calculated per student for each scenario by multiplying the likelihood of prescribing (student response) by the relative rank value of each drug in the scenario. This relative value index represented the treatment cost for that scenario. The composite treat- * Med > Pharm (P < 0.001) † Med, NP > Pharm (P <0.001; P = 0.005, respectively) ‡ Med > Pharm (P < 0.001) § Med > Pharm (P = 0.005) ment cost for each student was the sum of the relative value index for each of the 3 scenarios.
Additionally, 19 Likert-type items, adapted from previous studies, [7] [8] [9] were used to measure students' interactions with PSRs and their attitudes toward such interactions (see Table 4 ). Surveys were distributed at senior exit meetings to all students who attended in an anonymous fashion. Surveys were distributed once only; nonresponders were not tracked.
Analyses
Means and standard deviations (SD) are reported. Kruskal Wallis one-way ANOVA (alpha = 0.05) and Bonferroni-adjusted Mann Whitney U post hoc comparisons (alpha < 0.017) were used to assess differences among the 3 groups on the costs of pharmacotherapy decisions based on the relative value index and interactions with PSRs.
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RESULTS
Fifty-nine of 108 (54.6%) medical students, 53 of 94 (56.4%) pharmacy students, and 17 of 17 (100%) nurse practitioner students completed surveys. Table 1 lists student demographic data. Descriptive statistics and resulting pharmacotherapeutic decisions for the composite costs, and each clinical scenario are presented in Tables  2 and 3 . There were significant differences among groups for the total composite cost (P < .001) and for all 3 of the specific scenario items (tendinitis χ2 = 22.1, P < 0.001; hypertension χ2 = 22.4, P < 0.001; UTI χ2 = 7.1, P = 0.029). Medical students were more expensive in their overall composite treatment costs than were pharmacy students (P < 0.001). There were no differences in overall treatment costs associated with nurse practitioner students relative to those associated with medical or pharmacy students. Both medical and nurse practitioner students chose more expensive treatments for tendinitis than did pharmacy students (P < 0.001, P = 0.005, respectively). There was no difference between the prescribing costs associated with medical and nurse practitioner students. Medical students chose more expensive treatments for hypertension than the pharmacy students (P < 0.001). There was no difference in costs associated with nurse practitioner students compared with those incurred by medical or pharmacy students. Finally, medical students chose more expensive treatment choices for UTI than pharmacy students (P = 0.007).
Results from survey items used to assess student attitudes toward interactions with PSRs are listed in Table 4 . There were significant differences among groups on 5 items: the provision of useful and accurate information by PSRs for already established drugs (P = 0.010); the support of important conferences by PSRs (P = 0.037); whether PSRs should be banned from presentations at students' respective institution (P < 0.001); the impact of PSRs on student prescribing/recommendation behavior (P = 0.004); and the impact of promotional gifts from PSRs on student prescribing/recommendation behavior (P = 0.003).
Both medical and nurse practitioner students were more agreeable than pharmacy students that PSRs provide useful and accurate information for already established drugs (P = 0.012, P = 0.012, respectively). Medical students were more agreeable than nurse practitioner students that PSRs helped support conferences and speeches (P = 0.012). Pharmacy students were more agreeable than medical students on banning PSRs from presentation at their institutions (P < 0.001). Pharmacy students were more agreeable than nurse practitioner students that conversations with PSRs had no impact on their prescribing behavior (or drug recommending behavior for the pharmacy student) (P = 0.002). Pharmacy students also were more agreeable than medical students that promotional gifts from PSRs had no impact on their prescribing (or drug recommending behavior for the pharmacy student) behavior (P = 0.001).
Concerning attitudes toward the appropriateness of receiving gifts from PSRs, there were significant differences among the groups about receiving drug samples for patient use and personal use (P < 0.001 and P < 0.001, respectively). Both medical students (P < 0.001) and nurse practitioner students (P < 0.001) were more agreeable to receiving drug samples for patient use than were pharmacy students. Also, both medical (P < 0.001) and nurse practitioner students (P = 0.004) were more agreeable to receiving drug samples for personal use than were pharmacy students.
Students were asked to report the frequency of their monthly interactions with PSRs. Medical students reported a mean of 10.6 interactions per month (SD = 24.3), pharmacy students a mean of 3.0 interactions per month (SD = 3.1), and nurse practitioners 10.4 interactions per month (SD = 11.5). There was a significant difference among groups in the number of these interactions (P < 0.001). Both medical (P = 0.002) and nurse practitioner (P = 0.002) students reported interacting more frequently per month with PSRs than did pharmacy students.
DISCUSSION
We found that health professional students' decisions regarding pharmacotherapy costs are formed, at least in part, prior to graduation. Both groups with prescriptive authority (medical and nurse practitioner students) shared similar knowledge and attitudes regarding the pharmaceutical industry, their PSRs, and the costs of drug therapy. Thus, the influence of the pharmaceutical industry is found in at least 2 health professions with prescriptive authority.
Positive attitudes toward PSRs tended to increase with the number of interactions with PSRs. Pharmacy students had the fewest interactions and tended to be the most skeptical of PSR information. Pharmacy students also chose equally effective agents that were the least expensive as reflected in the calculated composite cost. On the other hand, medical and nurse practitioner students interacted more frequently with PSRs, possessed more positive attitudes toward PSRs in general, and prescribed more expensive agents based on the composite cost. It may be that pharmacy students have fewer interactions with PSRs, PSRs have less influence on pharmacy student attitudes, and heavily marketed drugs are not their first choice for uncomplicated medical scenarios.
The number of interactions with PSRs as a factor influencing practitioner attitudes and behaviors was recently explored. 11 McCormick and colleagues examined the long-term effect of policies restricting contact between internal medicine residents and PSRs. Their objective was to see if such policies affected physician attitudes and behaviors several years after completion of training. Their main outcome measures were physician attitude toward PSR information and frequency of contacts after training. They found that physicians who trained under a restrictive policy were less likely to view PSR information as beneficial in guiding therapeutic decision-making several years after training when compared to practitioners who trained in institutions without such restrictive policies. Also, physicians who trained under restrictive policies had less contact with PSRs when compared to practitioners without the restrictive policies. The investigators found that greater frequency of contact with PSRs during training was a predictor of increased perceived benefit of PSR information. There is also evidence that suggests the more a primary care physician uses drug information provided by PSRs, the higher the prescribing costs for nonacademic group practices. 8 Our results in health professional students were consistent with these findings.
To our knowledge this is the first study to investigate what factors may influence prescribing costs and at what level in training the influence of the pharmaceutical industry becomes evident. The differences observed between pharmacy students and medical and nurse practitioner students may reflect differences in the number of interactions with PSRs or in differences among professional curricula. We were not able to find any publications that explored the relationship between curricula and costs of prescribing. Pharmacy curricula place significant emphasis on pharmacotherapeutics, drug information, and literature evaluation. Pharmacotherapeutics as a course emphasizes patient-specific therapy using evidence-based outcomes. Drug information and drug literature evaluation courses may be important for clinical decision-making in professional practice. At our institution, pharmacy faculty members also teach the nurse practitioner pharmacotherapeutics course. This fact may in part account for the lower drug costs observed with pharmacy and nurse practitioner student decisions. Although the factors that affect pharmacotherapy costs have yet to be fully understood, curricular content and interactions with PSRs appear to be important.
Limitations
A number of potential factors may limit the generalizability of our conclusions. First, nurse practitioner students averaged 10 years of previous experience as registered nurses. One may assume that during this time interactions with PSRs occurred. Therefore, these previous interactions may have influenced their opinions regarding PSRs and confounded our results. Another limitation is the practice environment in which clinical training occurs. This environment may have a substantial influence on trainee attitudes and behavior. For example, pharmacy preceptors may display different attitudes toward PSRs than do medicine preceptors and this difference may influence student attitudes and account, at least in part, for the differences we observed. McCormick's recent report of the long-term effect on trainee attitudes and practice of institutional limits on pharmaceutical detailing highlights the importance of the clinical training environment. 11 Our investigation did not control for differences in learning environment influences.
